Word

OSLUNVAY

Status

Pending

Status Code

730

Status Date

Monday, February 12, 2024

Serial Number

97587309

Mark Type

4000

Filing Date

Monday, September 12, 2022

Published for Opposition

Tuesday, July 11, 2023

Trademark Owner History

Eli Lilly and Company - Owner At Publication

Classifications

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Trademark Events

Feb 26, 2024

Assigned To Examiner

Feb 13, 2024

Notice Of Approval Of Extension Request E-Mailed

Feb 12, 2024

Sou Extension 1 Granted

Feb 12, 2024

Sou Extension 1 Filed

Feb 12, 2024

Sou Teas Extension Received

Sep 5, 2023

Noa E-Mailed - Sou Required From Applicant

Jul 11, 2023

Official Gazette Publication Confirmation E-Mailed

Jul 11, 2023

Published For Opposition

Jun 21, 2023

Notification Of Notice Of Publication E-Mailed

Jun 5, 2023

Approved For Pub - Principal Register

Jun 3, 2023

Assigned To Examiner

Sep 27, 2022

New Application Office Supplied Data Entered

Sep 15, 2022

New Application Entered